• Product NameDDAH2 Rabbit mAb
• Host SpeciesRecombinant Rabbit
• Clonality Monoclonal antibody
• Clone No.JB59-33
• PurificationProA affinity purified
• ApplicationsWB,IP
• Species ReactivityHu, Ms, Rt
• Immunogen DescriptionSynthetic peptide within Human DDAH2 aa 1-100
• Alternative Names    DDAH antibody
  DDAH II antibody
  DDAH-2 antibody
  DDAH2 antibody
  DDAH2_HUMAN antibody
  DDAHII antibody
  Dimethylargininase 2 antibody
  Dimethylargininase-2 antibody
  Dimethylarginine dimethylaminohydrolase 2 antibody
  Dimethylarginine dimethylaminohydrolase II antibody
  G6a antibody
  N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 antibody
  NG dimethylarginine dimethylamino hydrolase homolog antibody
  NG30 antibody
  OTTHUMP00000029307 antibody
  OTTHUMP00000029310 antibody
  OTTHUMP00000174488 antibody
  OTTHUMP00000174489 antibody
  Protein G6a antibody
  S phase protein antibody
  S-phase protein antibody
  
• Accession No. Swiss-Prot#:O95865
• UniprotO95865
• Gene ID23564;
• Calculated MW 30kDa
• Formulation 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
• Storage Store at -20˚C

• WB: 1:2,000-1:5,000
  
  
  IP: 1:10-:50
  

DDAH, a dimethylarginine dimethylaminohydrolase, hydrolyzes dimethyl arginine (ADMA) and monomethyl arginine (MMA), both inhibitors of nitric oxide synthases, and may be involved in in-vivo modulation of nitric oxide production. Impairment of DDAH causes ADMA accumulation and a reduction in cGMP generation. DDAH II, the predominant DDAH isoform in endothelial cells, facilitates the induction of nitric oxide synthesis by all-trans-Retinoic acid (atRA). DDAH proteins are highly expressed in colon, kidney, stomach and liver tissues.

• Western blot analysis of DDAH2 on different tissue lysates using anti-DDAH2 antibody at 1/2,000 dilution.
  Positive control:
  Lane 1: Rat heart
  Lane 2: Mouse heart
  Lane 3: Mouse lung
  Lane 4: Human lung
  

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting